Evaluation of Percutaneous Absorption of Esculetin: Effect of Chemical Enhancers

Sergio del Rio Sancho; César Eulogio Serna Jiménez; María Aracely Calatayud Pascual; Cristina Balaguer Fernández; Andrés Femenía Font; Encarna Castillo García; Virginia Merino; Alicia López Castellano

doi:10.1055/s-0032-1328058

Planta Medica, Inhaltsverzeichnis

Planta Med 2013; 79(02): 131-136
DOI: 10.1055/s-0032-1328058

Pharmacokinetic Investigations

Original Papers

Georg Thieme Verlag KG Stuttgart · New York

Evaluation of Percutaneous Absorption of Esculetin: Effect of Chemical Enhancers

Sergio del Rio Sancho

¹Instituto de Ciencias Biomédicas, Departamento de Farmacia, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Valencia, Spain

,

César Eulogio Serna Jiménez

¹Instituto de Ciencias Biomédicas, Departamento de Farmacia, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Valencia, Spain

,

María Aracely Calatayud Pascual

¹Instituto de Ciencias Biomédicas, Departamento de Farmacia, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Valencia, Spain

,

Cristina Balaguer Fernández

¹Instituto de Ciencias Biomédicas, Departamento de Farmacia, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Valencia, Spain

,

Andrés Femenía Font

¹Instituto de Ciencias Biomédicas, Departamento de Farmacia, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Valencia, Spain

,

Encarna Castillo García

¹Instituto de Ciencias Biomédicas, Departamento de Farmacia, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Valencia, Spain

,

Virginia Merino

²Centro de Reconocimiento Molecular y Desarrollo Tecnológico, Centro Mixto Universidad Politécnica de Valencia – Universidad de Valencia, Departamento de Farmacia y Tecnología Farmacéutica, Universidad de Valencia, Valencia, Spain

,

Alicia López Castellano

¹Instituto de Ciencias Biomédicas, Departamento de Farmacia, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Valencia, Spain

› Institutsangaben

Abstract

Percutaneous transdermal absorption of esculetin (6,7-dihydroxycoumarin), an oxidative damage inhibitor, was evaluated by means of in vitro permeation studies in which vertical Franz-type diffusion cells and pig ear skin were employed. To determine the absorption of esculetin, we validated a simple, accurate, precise, and rapid HPLC-UV method. Additionally, the effects of several percutaneous enhancers were studied. Pretreatment of porcine skin was performed with ethanol (control vehicle), decenoic acid, oleic acid, R-(+)-limonene, and laurocapram (Azone®) (5 % in ethanol, w/w, respectively). Pretreatment of skin with oleic acid or laurocapram led to statistically significant differences in the transdermal flux of esculetin with respect to controls. Of the two enhancers, laurocapram showed the greatest capacity to enhance the flux of esculetin across pig skin.

Key words

esculetin - absorption enhancer - in vitro model - transdermal drug delivery

Volltext

Referenzen

References
1 Chang WS, Lin CC, Chuang SC, Chiang HC. Superoxide anion scavenging effect of coumarins. Am J Chin Med 1996; 24: 11-17
2 Masamoto Y, Ando H, Murata Y, Shimoishi Y, Tada M, Takahata K. Mushroom tyrosinase inhibitory activity of esculetin isolated from seeds of Euphorbia lathyris L. Biosci Biotechnol Biochem 2003; 67: 631-634
3 Neichi T, Koshihara Y, Murota S. Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis. Biochim Biophys Acta 1983; 753: 130-132
4 Egan D, OʼKennedy R, Moran E, Cox D, Prosser E, Thornes RD. The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab Rev 1990; 22: 503-529
5 Schimmer O, Eschelbach H. Esculetin in Alchemilla speciosa: identification and antimutagenic properties. Pharmazie 1997; 52: 476-478
6 Martín-Aragón S, Benedi JM, Villar AM. Effects of the antioxidant (6,7-dihydroxycoumarin) esculetin on the glutathione system and lipid peroxidation in mice. Gerontology 1998; 44: 21-25
7 Lin WL, Wang CJ, Tsai YY, Liu CL, Hwang JM, Tseng TH. Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver. Arch Toxicol 2000; 74: 467-472
8 Elliott S, Rowan AD, Carrere S, Koshy P, Catterall JB, Cawston TE. Esculetin inhibits cartilage resorption induced by interleukin 1alpha in combination with oncostatin M. Ann Rheum Dis 2001; 60: 158-165
9 Matsunaga K, Yoshimi N, Yamada Y, Shimizu M, Kawabata K, Ozawa Y, Hara A, Mori H. Inhibitory effects of nabumetone, a cyclooxygenase-2 inhibitor, and esculetin, a lipoxygenase inhibitor, on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats. Jpn J Cancer Res 1998; 89: 496-501
10 Noguchi M, Kitagawa H, Miyazaki I, Mizukami Y. Influence of esculetin on incidence, proliferation, and cell kinetics of mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene in rats on high- and low-fat diets. Jpn J Cancer Res 1993; 84: 1010-1014
11 Yang J, Xiao YL, He XR, Qiu GF, Hu XM. Aesculetin-induced apoptosis through a ROS-mediated mitochondrial dysfunction pathway in human cervical cancer cells. J Asian Nat Prod Res 2010; 12: 185-193
12 Park C, Jin CY, Kim GY, Choi IW, Kwon TK, Choi BT, Lee SJ, Lee WH, Choi YH. Induction of apoptosis by esculetin in human leukemia U937 cells through activation of JNK and ERK. Toxicol Appl Pharmacol 2008; 227: 219-228
13 Yang JY, Della-Fera MA, Hartzell DL, Nelson-Dooley C, Hausman DB, Baile CA. Esculetin induces apoptosis and inhibits adipogenesis in 3 T3-L1 cells. Obesity 2006; 14: 1691-1699
14 Kaneko T, Tahara S, Takabayashi F. Suppression of lipid hydroperoxide-induced oxidative damage to cellular DNA by esculetin. Biol Pharm Bull 2003; 26: 840-844
15 Tahara S, Baba N, Matsuo M, Kaneko T. Protective effect of epigallocatechin gallate and esculetin on oxidative DNA damage induced by psoralen plus ultraviolet-A therapy. Biosci Biotechnol Biochem 2005; 69: 620-622
16 Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database Syst Rev 2002; CD003230
17 Ghafourian T, Zandasrar P, Hamishekar H, Nokhodchi A. The effect of penetration enhancers on drug delivery through skin: a QSAR study. J Control Release 2004; 99: 113-125
18 Moghimi HR, Williams AC, Barry BW. Enhancement by terpenes of 5-fluorouracil permeation through the stratum corneum: model solvent approach. J Pharm Pharmacol 1998; 50: 955-964
19 Ibrahim SA, Li SK. Efficiency of fatty acids as chemical penetration enhancers: mechanisms and structure enhancement relationship. Pharm Res 2010; 27: 115-125
20 Femenía-Font A, Balaguer-Fernández C, Merino V, Rodilla V, López-Castellano A. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate. Eur J Pharm Biopharm 2005; 61: 50-55
21 Jenke DR. Chromatographic method validation: a review of current practices and procedures. I. General concepts and guidelines. J Liq Chrom Rel Technol 1996; 19: 719-736
22 Jenke DR. Chromatographic method validation: a review of current practices and procedures. II. Guidelines for primary validation parameters. J Liq Chrom Rel Technol 1996; 19: 737-757
23 OECD. Test No. 428: Skin absorption: In vitro method. OECD guidelines for the testing of chemicals, Section 4. Paris: OECD Publishing; 2004
24 López A, Llinares F, Cortell C, Herráez M. Comparative enhancer effects of Span20 with Tween20 and Azone on the in vitro percutaneous penetration of compounds with different lipophilicities. Int J Pharm 2000; 202: 133-140
25 Borrás-Blasco J, Díez-Sales O, López A, Herráez-Domínguez M. A mathematical approach to predicting the percutaneous absorption enhancing effect of sodium lauryl sulphate. Int J Pharm 2004; 269: 121-129
26 Scheuplein RJ. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol 1967; 48: 79-88
27 Lacy A, OʼKennedy R. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr Pharm Des 2004; 10: 3797-3811
28 Zhou L, Kang J, Fan L, Ma XC, Zhao HY, Han J, Wang BR, Guo DA. Simultaneous analysis of coumarins and secoiridoids in Cortex Fraxini by high-performance liquid chromatography-diode array detection-electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal 2008; 47: 39-46
29 Tsai TH, Huang CT, Shum AY, Chen CF. Simultaneous blood and biliary sampling of esculetin by microdialysis in the rat. Life Sci 1999; 65: 1647-1655
30 Shi Z, Zhu X, Zhang H. Micelle-mediated extraction and cloud point preconcentration for the analysis of aesculin and aesculetin in Cortex fraxini by HPLC. J Pharm Biomed Anal 2007; 44: 867-873
31 Tetko IV, Gasteiger J, Todeschini R, Mauri A, Livingstone D, Ertl P, Palyulin VA, Radchenko EV, Zefirov NS, Makarenko AS, Tanchuk VY, Prokopenko VV. Virtual computational chemistry laboratory – design and description. J Comput Aid Mol Des 2005; 19: 453-463
32 del Rio-Sancho S, Serna-Jimenez CE, Calatayud-Pascual A, Balaguer-Fernandez C, Femenia-Font A, Merino V, Lopez-Castellano A. Transdermal absorption of memantine. Effect of chemical enhancers, iontophoresis and role of enhancer lipophilicity. Eur J Pharm Biopharm 2012; 82: 164-170
33 Lewis D, Hadgraft J. Mixed monolayers of dipalmitolphospatidyl-choline with Azone or oleic acid at the air-water interface. Int J Pharm Sci 1990; 75: 176-181
34 Díez-Sales O, Watkinson AC, Herráez-Domínguez M, Javaloyes C, Hadgraft J. A mechanistic investigation of the in vitro human permeation enhancing effect of Azone®. Int J Pharm 1996; 129: 33-40
35 Williams AC, Barry BW. Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement. Pharm Res 1991; 8: 17-24